INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,750,350 | -39.1% | 861,400 | -49.1% | 0.16% | -10.6% |
| Q2 2023 | $35,687,464 | +23.8% | 1,691,349 | 0.0% | 0.18% | -3.7% |
| Q1 2023 | $28,837,500 | -6.4% | 1,691,349 | +9.7% | 0.19% | -23.7% |
| Q4 2022 | $30,796,153 | +2.8% | 1,541,349 | +10.8% | 0.24% | +28.3% |
| Q3 2022 | $29,970,000 | +140.5% | 1,391,349 | +120.2% | 0.19% | +161.6% |
| Q2 2022 | $12,460,000 | -16.1% | 631,849 | 0.0% | 0.07% | +9.0% |
| Q1 2022 | $14,848,000 | -69.7% | 631,849 | -64.9% | 0.07% | -63.6% |
| Q4 2021 | $48,983,000 | -1.1% | 1,798,209 | 0.0% | 0.18% | -8.9% |
| Q3 2021 | $49,523,000 | +85.8% | 1,798,209 | +92.0% | 0.20% | +74.1% |
| Q2 2021 | $26,651,000 | -16.4% | 936,438 | 0.0% | 0.12% | -41.1% |
| Q1 2021 | $31,895,000 | +36.6% | 936,438 | +33.5% | 0.20% | +39.7% |
| Q4 2020 | $23,346,000 | – | 701,301 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |